fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) Supply Disruption — QuVa Pharma, Inc. (Moderate Ri
fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) Supply Disruption — QuVa Pharma, Inc. (Moderate Ri is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL); Manufacturer: QuVa P
| Drug name | fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) |
|---|---|
| Manufacturer | QuVa Pharma, Inc. |
| Recall/Disruption reason | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0561-2020 |
| Initiation date | 20191112 |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →